Temporal Dynamics of Anti–Type 1 Interferon Autoantibodies in Patients With Coronavirus Disease 2019

Authors:

Abstract
Binding levels and neutralization activity of anti–type 1 interferon autoantibodies peaked during acute coronavirus disease 2019 and markedly decreased thereafter. Most patients maintained some ability to neutralize type 1 interferon into convalescence despite lower levels of binding immunoglobulin G. Identifying these autoantibodies in healthy individuals before the development of critical viral disease may be challenging.
Funding Information
  • Intramural Research Program
  • National Institute of Allergy and Infectious Diseases
  • National Institutes of Health (1ZIAAI001265, 1ZIAAI001265, 1ZIAAI001312, 1ZIAAI001270, 1ZIAAI001318)
  • Regione Lombardia, Italy